Viewing nowCombinationDucarb Tablet 30/5 mg
Fimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.

MFDS item code 201603068 · Approved 2016.05.30 · Insurance code 641906500
Treatment of essential hypertension not controlled with fimasartan potassium monotherapy
This medication is used to effectively manage blood pressure when adequate control has not been achieved with monotherapy using Pimasartan Potassium in patients with essential hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using fimasartan before starting this medicine. However, switching directly to this medicine may be considered if blood pressure is not controlled, as follows: ㆍ 30/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 30/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy or 30/5 mg. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or 60/5 mg. Patients taking fimasartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Older adults No initial dose adjustment is necessary in older adults aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.
This medication can cause serious harm or even death to the fetus or newborn if taken during the second or third trimester of pregnancy, therefore it must be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any of the active ingredients or similar components, those who are pregnant or breastfeeding, those undergoing renal dialysis, those with moderate to severe liver impairment, those with biliary obstruction, those with certain genetic lactose intolerance, patients with severe aortic stenosis or in shock should not take this medication. Patients with reduced blood volume or sodium, those with impaired kidney function, patients with renovascular hypertension, those with aortic and mitral stenosis, patients with primary aldosteronism, patients with severe hypotension, the elderly, and patients with allergies to specific pigment components should use this medication with caution. This medication may cause side effects such as dizziness, headache, facial swelling, difficulty in urination, insomnia, and flushing, and rare reports of renal dysfunction, hypotension, muscle problems, and skin rash have been noted. Due to the risk of hypotension or electrolyte imbalance, patients taking diuretics or those with restricted sodium intake should exercise caution. Patients with heart failure or weakened kidney function should have their serum potassium levels checked regularly due to the increased risk of elevated serum potassium. Renovascular hypertension patients should be closely monitored due to the risk of worsening kidney function. Taking this medication in combination with other renin-angiotensin system drugs may increase the risk of decreased kidney function, hypotension, and hyperkalemia; therefore, such combinations are not recommended. If symptoms of sudden hypotension occur while taking this medication, it is essential to inform healthcare professionals immediately. Caution is required while driving or operating dangerous machinery since drowsiness or dizziness may occur with this medication. Women who are pregnant or breastfeeding should avoid taking this medication and consult a specialist if necessary. Safety and efficacy in children under the age of 18 have not been established, so its use is not recommended. In case of overdose, there may be hypotension, palpitations, or in severe cases, shock; therefore, immediate emergency treatment is required. This medication should be kept out of the reach of children, and it is safer not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and must be stored in a special container that prevents light exposure. Additionally, it is important to store it at room temperature between 1 to 30 degrees Celsius to maintain its effectiveness.
White apple-shaped film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
Fimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Fimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Fimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Fimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.